menu ☰
menu ˟

FDA approves Dupixent for chronic rhinosinusitis with nasal polyps

26 Jun 2019
The FDA approved Dupixent for use with other medicines to treat patients with chronic rhinosinusitis with nasal polyps, the agency, Regeneron Pharmaceuticals and Sanofi all announced today.“Dupixent is the first FDA-approved medicine for adults wit...

Click here to view the full article which appeared in Allergy Immunology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.